Skip to main content
Boehringer Ingelheim Logo
JASCAYD® (nerandomilast) tablets
For Healthcare Professionals
Products
Therapeutic Areas
Resources
Logout
JASCAYD® Logo
JASCAYD® (nerandomilast) tablets
  • Home
  • PPF

    • PPF
    • JASCAYD® for progressive pulmonary fibrosis(PPF)
    • About PPF
    • About autoimmune ILDs
    • Trial design in PPF
    • Efficacy: primary endpoint results in PPF
    • Efficacy: key secondary endpoint results in PPF
    • Efficacy: other exploratory analyses in PPF
    • Safety and tolerability in PPF
    • Autoimmune ILD subgroup results
  • IPF

    • IPF
    • JASCAYD® for IPF
    • About IPF
    • Trial design in IPF
    • Efficacy: primary endpoint results in IPF
    • Efficacy: key secondary endpoint results in IPF
    • Efficacy: progression-free survival in IPF
    • Safety and tolerability in IPF
  • MOD/MOA
  • Dosing
  • Resources
  • Products
  • Therapeutic Areas
  • Resources
  • Logout
  • Boehringer Ingelheim Logo
    JASCAYD® (nerandomilast) tablets

    JASCAYD® (nerandomilast) tablets

    Sitemap

    • Home
    • PPF
      • JASCAYD® for progressive pulmonary fibrosis (PPF)
      • About PPF
      • About autoimmune ILDs
      • Trial design in PPF
      • Efficacy: primary endpoint results in PPF
      • Efficacy: key secondary endpoint results in PPF
      • Efficacy: other exploratory analyses in PPF
      • Safety and tolerability in PPF
      • Autoimmune ILD subgroup results
    • IPF
      • JASCAYD® for IPF
      • About IPF
      • Trial design in IPF
      • Efficacy: primary endpoint results in IPF
      • Efficacy: key secondary endpoint results in IPF
      • Efficacy: progression-free survival in IPF
      • Safety and tolerability in IPF
    • MOD/MOA
    • Dosing
    • Resources

    MLR ID: PC-AE-102896
    Expiry Date: 10/05/2028

    Vault id: WP-AE-100005

    • Accessibility StatementOpens in new tab
    • Terms of UseOpens in new tab
    • Privacy StatementOpens in new tab
    • Contact UsOpens in new tab
    • Sitemap

    Boehringer Ingelheim Logo
    Boehringer Ingelheim Logo

    Copyright © 2026, Boehringer Ingelheim International GmbH. All rights reserved.